Switch theme
Sign up to access all valuation multiples
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
2019
1.6K+
LTM Revenue $1.8B
LTM EBITDA $236M
$12.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hims & Hers Health has a last 12-month revenue (LTM) of $1.8B and a last 12-month EBITDA of $236M.
In the most recent fiscal year, Hims & Hers Health achieved revenue of $1.5B and an EBITDA of $79.0M.
Hims & Hers Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Hims & Hers Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $1.4B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 79% | XXX | XXX | XXX |
| EBITDA | $236M | XXX | $79.0M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 5% | XXX | XXX | XXX |
| EBIT | $111M | XXX | $61.9M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $148M | XXX | $126M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Hims & Hers Health's stock price is $57.
Hims & Hers Health has current market cap of $12.7B, and EV of $12.4B.
See Hims & Hers Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.4B | $12.7B | XXX | XXX | XXX | XXX | $0.58 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Hims & Hers Health has market cap of $12.7B and EV of $12.4B.
Hims & Hers Health's trades at 8.4x EV/Revenue multiple, and 157.0x EV/EBITDA.
Equity research analysts estimate Hims & Hers Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hims & Hers Health has a P/E ratio of 85.3x.
See valuation multiples for Hims & Hers Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12.7B | XXX | $12.7B | XXX | XXX | XXX |
| EV (current) | $12.4B | XXX | $12.4B | XXX | XXX | XXX |
| EV/Revenue | 6.8x | XXX | 8.4x | XXX | XXX | XXX |
| EV/EBITDA | 52.5x | XXX | 157.0x | XXX | XXX | XXX |
| EV/EBIT | 111.4x | XXX | 200.3x | XXX | XXX | XXX |
| EV/Gross Profit | 8.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 85.3x | XXX | 100.4x | XXX | XXX | XXX |
| EV/FCF | 53.6x | XXX | 62.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHims & Hers Health's last 12 month revenue growth is 39%
Hims & Hers Health's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.7M for the same period.
Hims & Hers Health's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hims & Hers Health's rule of X is 110% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hims & Hers Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 39% | XXX | 39% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 52% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 37% | XXX | 44% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 110% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 46% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| UniDoc Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ping An Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hims & Hers Health acquired XXX companies to date.
Last acquisition by Hims & Hers Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Hims & Hers Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Hims & Hers Health founded? | Hims & Hers Health was founded in 2019. |
| Where is Hims & Hers Health headquartered? | Hims & Hers Health is headquartered in United States of America. |
| How many employees does Hims & Hers Health have? | As of today, Hims & Hers Health has 1.6K+ employees. |
| Who is the CEO of Hims & Hers Health? | Hims & Hers Health's CEO is Mr. Andrew Dudum. |
| Is Hims & Hers Health publicy listed? | Yes, Hims & Hers Health is a public company listed on NYS. |
| What is the stock symbol of Hims & Hers Health? | Hims & Hers Health trades under HIMS ticker. |
| When did Hims & Hers Health go public? | Hims & Hers Health went public in 2021. |
| Who are competitors of Hims & Hers Health? | Similar companies to Hims & Hers Health include e.g. Doctor Care Anywhere, UniDoc Health, Ping An Healthcare, Kooth. |
| What is the current market cap of Hims & Hers Health? | Hims & Hers Health's current market cap is $12.7B |
| What is the current revenue of Hims & Hers Health? | Hims & Hers Health's last 12 months revenue is $1.8B. |
| What is the current revenue growth of Hims & Hers Health? | Hims & Hers Health revenue growth (NTM/LTM) is 39%. |
| What is the current EV/Revenue multiple of Hims & Hers Health? | Current revenue multiple of Hims & Hers Health is 6.8x. |
| Is Hims & Hers Health profitable? | Yes, Hims & Hers Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hims & Hers Health? | Hims & Hers Health's last 12 months EBITDA is $236M. |
| What is Hims & Hers Health's EBITDA margin? | Hims & Hers Health's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Hims & Hers Health? | Current EBITDA multiple of Hims & Hers Health is 52.5x. |
| What is the current FCF of Hims & Hers Health? | Hims & Hers Health's last 12 months FCF is $231M. |
| What is Hims & Hers Health's FCF margin? | Hims & Hers Health's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Hims & Hers Health? | Current FCF multiple of Hims & Hers Health is 53.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
